Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy

M Chehelgerdi, M Chehelgerdi… - Molecular cancer, 2024‏ - Springer
The CRISPR system is a revolutionary genome editing tool that has the potential to
revolutionize the field of cancer research and therapy. The ability to precisely target and edit …

Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing

J Tao, DE Bauer, R Chiarle - Nature Communications, 2023‏ - nature.com
CRISPR-Cas gene editing has revolutionized experimental molecular biology over the past
decade and holds great promise for the treatment of human genetic diseases. Here we …

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

A Cherubini, M Ostadreza, O Jamialahmadi, S Pelusi… - Nature Medicine, 2023‏ - nature.com
Fatty liver disease (FLD) caused by metabolic dysfunction is the leading cause of liver
disease and the prevalence is rising, especially in women. Although during reproductive …

CRISPR gene therapy: applications, limitations, and implications for the future

F Uddin, CM Rudin, T Sen - Frontiers in oncology, 2020‏ - frontiersin.org
A series of recent discoveries harnessing the adaptive immune system of prokaryotes to
perform targeted genome editing is having a transformative influence across the biological …

[HTML][HTML] Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy

MF Rasul, BM Hussen, A Salihi, BS Ismael, PJ Jalal… - Molecular Cancer, 2022‏ - Springer
CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats-associated protein
9) shows the opportunity to treat a diverse array of untreated various genetic and …

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

Y Lu, J Xue, T Deng, X Zhou, K Yu, L Deng, M Huang… - Nature medicine, 2020‏ - nature.com
Clustered regularly interspaced short palindromic repeats (CRISPR)–Cas9 editing of
immune checkpoint genes could improve the efficacy of T cell therapy, but the first necessary …

Nanoparticle delivery of CRISPR/Cas9 for genome editing

L Duan, K Ouyang, X Xu, L Xu, C Wen, X Zhou… - Frontiers in …, 2021‏ - frontiersin.org
The emerging clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-
associated system (Cas) gene-editing system represents a promising tool for genome …

Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis

PJ Hsu, Y Zhu, H Ma, Y Guo, X Shi, Y Liu, M Qi, Z Lu… - Cell research, 2017‏ - nature.com
Abstract N 6-methyladenosine (m 6 A) is the most common internal modification in
eukaryotic mRNA. It is dynamically installed and removed, and acts as a new layer of mRNA …

m6A facilitates hippocampus-dependent learning and memory through YTHDF1

H Shi, X Zhang, YL Weng, Z Lu, Y Liu, Z Lu, J Li, P Hao… - Nature, 2018‏ - nature.com
Abstract N 6-methyladenosine (m6A), the most prevalent internal RNA modification on
mammalian messenger RNAs, regulates the fates and functions of modified transcripts …

Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids

R Ouchi, S Togo, M Kimura, T Shinozawa, M Koido… - Cell metabolism, 2019‏ - cell.com
Human organoid systems recapitulate in vivo organ architecture yet fail to capture complex
pathologies such as inflammation and fibrosis. Here, using 11 different healthy and …